News
Management of hemato-oncological patients in Covid-19 times
When Covid-19 pandemic had just started, the Clinic Hematology group published a series of recommendations for the management of cancer patients. Now, have the recommended measures been implemented? Have they been effective? We have discussed this with those responsible of the study.
A study with IDIBELL participation determines the optimal number of chemotherapy cycles to treat glioblastoma
The clinical trial, published in the journal ‘Neuro Oncology’, shows that increasing the number of cycles of temozolomide in patients with this type of tumor does not provide additional benefits and increases the toxicity of the treatment.
A new study analyzes the molecular concordance between primary colorectal cancer tumors and their respective liver metastasis
IDIBELL and ICO researchers participate in the classification into molecular subtypes of pairs of colorectal cancers and liver metastases to define their correlation.
Dr. Victor Moreno will be the Guest Editor of a special issue of Nutrients journal
Dr. Víctor Moreno will be the guest editor of a special issue of Nutrientes journal that will focus on the role of food in cancer.
Nandu Jubany launches solidarity masks for research against the coronavirus
The funds raised will be used for research projects that IDIBELL has started together with the Bellvitge University Hospital and the Catalan Institute of Oncology.
Dr. Anna Veiga’s project to improve genetic edition of human embryos receives Merck Research Grant
The project aims to develop the CRISPR/Cas9 genetic edition technique in human embryos to study their development
A new platform for the diagnosis of autoimmune encephalitis receives funding from the ERC Proof of Concept grants
The stem cell-based platform would enable a more accurate diagnosis of the disease, as it would detect with high precision a wide range of autoantibodies.
“The research will bring us the knowledge to be able to attack the pandemic” Sebastià Videla
Sebastià tested positive for COVID-19 on March 24, and in this interview, he tells us how he has lived the confinement since then and the reflections he has reached.
Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.